Biopac India Corporation Ltd. announced audited standalone earnings results for the fourth quarter and year ended March 31, 2016. For the quarter, the company reported net sales/income from operations of INR 124.800 million against INR 162.519 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 3.470 million against INR 3.379 million a year ago. Loss from ordinary activities before tax was INR 6.078 million against INR 1.845 million a year ago. Net loss was INR 6.165 million or INR 0.36 per basic and diluted share before and after extraordinary items against INR 2.057 million or INR 0.12 per basic and diluted share before and after extraordinary items a year ago. For the year, the company reported net sales/income from operations of INR 520.969 million against INR 585.580 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 46.035 million against INR 24.674 million a year ago. Profit from ordinary activities before tax was INR 7.477 million against INR 8.356 million a year ago. Net profit was INR 0.519 million or INR 0.03 per basic and diluted share before and after extraordinary items against INR 8.753 million or INR 0.51 per basic and diluted share before and after extraordinary items a year ago.